China Telemedicine: 400M Users, AI Diagnosis Accuracy 95%

China's telemedicine system differs from Western telehealth in scale, integration, and government involvement. China serves 400 million telemedicine users compared to approximately 100 million in the US, primarily because the Chinese government mandated internet hospital licensing and integrated telemedicine into the public health insurance system. In the US, telehealth grew rapidly during COVID-19 but remains fragmented across private insurers, with Medicare coverage varying by state. China's AI triage achieves 95% accuracy for common diseases and handles initial patient screening automatically, while Western systems rely more on human-first consultations. China's advantage lies in vertical integration: platforms like Ping An Good Doctor and JD Health combine AI diagnosis, doctor consultation, electronic prescribing, insurance claims processing, and pharmacy delivery in a single ecosystem. The US system typically splits these functions across multiple providers and insurers. China also invested heavily in rural telemedicine infrastructure through government subsidies, connecting 90% of county hospitals with urban specialists, while rural telehealth access in the US remains limited. However, the US leads in specialist telemedicine (especially mental health) and regulatory frameworks protecting patient data. China's approach is more centralized and government-driven, achieving faster scale but with less patient choice and data privacy protection compared to Western models.